Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8234332 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 8 Pages |
Abstract
Our results have confirmed that CRT is an effective approach. Patients with human immunodeficiency virus can be treated with CRT. Tumor mobility significantly predicts the outcome; the implications for management are discussed. We also discuss the treatment planning implications of the late morbidity findings. The substantial incidence of additional malignancies underscores the importance of full oncologic screening during follow-up.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Robert J. M.D., Ph.D., Elesyia D. M.D., Albert M.D., Ph.D., Elisa H. M.D., James W. M.D., Perry W. M.D., Ira J. M.D., Robert S. M.D., Ph.D., Matthew G. M.D., Parag M.D., Joel M.D., Benjamin R. M.D.,